Processa Pharmaceuticals (PCSA) Revenue (2012 - 2016)
Processa Pharmaceuticals' (PCSA) quarterly Revenue came in at $5000.0 in Q1 2016, down 86.76% on a YoY basis from $37760.0 in Q2 2015, and down 71.43% quarter-over-quarter from $17500.0 in Q4 2015.
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) Revenue (2012 - 2016) Analysis & Trends
Processa Pharmaceuticals (PCSA) has reported Revenue for 5 consecutive years, with $5000.0 the latest figure, recorded in Q1 2016.
- For the quarter ending Q1 2016, Revenue fell 86.76% year-over-year to $5000.0; the trailing twelve-month figure through Dec 2016 stood at $5000.0 (down 96.25% YoY), and the FY2016 full-year result was $5000.0, down 95.59% from the prior year.
- Revenue retreated to $5000.0 in Q1 2016 per PCSA's latest filing, from $17500.0 in the prior quarter.
- Across five years, Revenue topped out at $125910.0 in Q3 2013 and bottomed at $5000.0 in Q1 2016.
- Historically, Revenue has averaged $51797.9 across 5 years, with a median of $43409.0 in 2012.
- The sharpest annual moves came in 2013 and 2016: Revenue soared 156.66% in 2013, then sank 86.76% in 2016.
- Over 5 years, Revenue stood at $31451.0 in 2012, then surged by 122.85% to $70090.0 in 2013, then slumped by 79.45% to $14400.0 in 2014, then increased by 21.53% to $17500.0 in 2015, then tumbled by 71.43% to $5000.0 in 2016.
- According to Business Quant data, Revenue over the past three periods registered $5000.0, $17500.0, and $58165.0 for Q1 2016, Q4 2015, and Q3 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 15.03 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 13.48 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 1.67 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 783.30 Mn |
| 10 | Processa Pharmaceuticals | 5.75 Mn | 5.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | 5,000.00 |
| Dec 31, 2015 | 17,500.00 |
| Sep 30, 2015 | 58,165.00 |
| Jun 30, 2015 | 20,040.00 |
| Mar 31, 2015 | 37,760.00 |
| Dec 31, 2014 | 14,400.00 |
| Sep 30, 2014 | 52,621.00 |
| Jun 30, 2014 | 112,835.00 |
| Mar 31, 2014 | 20,435.00 |
| Dec 31, 2013 | 70,090.00 |
| Sep 30, 2013 | 125,910.00 |
| Jun 30, 2013 | 97,280.00 |
| Mar 31, 2013 | 19,200.00 |
| Dec 31, 2012 | 31,451.00 |
| Sep 30, 2012 | 49,058.00 |
| Jun 30, 2012 | 97,022.00 |